Detalhe da pesquisa
1.
Prediction of Acute Myocardial Injury in Noncardiac Surgery in Patients at Risk for Major Adverse Cardiovascular and Cerebrovascular Events: A Multivariable Risk Model.
Anesth Analg
; 137(6): 1116-1126, 2023 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37043386
2.
PCSK9 Inhibitors Have Apolipoprotein C-III-Related Anti-Inflammatory Activity, Assessed by 1H-NMR Glycoprotein Profile in Subjects at High or very High Cardiovascular Risk.
Int J Mol Sci
; 24(3)2023 Jan 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36768645
3.
Secondary prevention strategies after an acute ST-segment elevation myocardial infarction in the AMI code era: beyond myocardial mechanical reperfusion.
BMC Cardiovasc Disord
; 17(1): 54, 2017 Feb 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28173757
4.
Mortality and incidence of cardiovascular events in patients treated with aspirin and statins at one year after myocardial injury in noncardiac surgery: a prospective observational study.
Minerva Anestesiol
; 89(5): 415-424, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36287395
5.
An intensive, structured, mobile devices-based healthcare intervention to optimize the lipid-lowering therapy improves lipid control after an acute coronary syndrome.
Front Cardiovasc Med
; 9: 916031, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35958430
6.
Analysis of the prescription process of PCSK9 inhibitors in the cardiology departments of Spanish hospitals and optimization proposal. The IKIGAI study. / Análisis del proceso de prescripción de inhibidores PCSK9 en los servicios de cardiología de los hospitales españoles y propuesta de optimización. Estudio IKIGAI.
Clin Investig Arterioscler
; 33(6): 296-305, 2021.
Artigo
em Inglês, Espanhol
| MEDLINE | ID: mdl-34315626
7.
Implementation of clinical practices and pathways optimizing ACS patients lipid management: Focus on eight European initiatives.
Atheroscler Suppl
; 42: e59-e64, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-33589225
8.
A new rational approach to reach LDL-cholesterol concentration objectives after an acute coronary syndrome. / Una nueva estrategia para alcanzar los niveles objetivos de colesterol LDL tras un síndrome coronario agudo.
Clin Investig Arterioscler
; 31(3): 93-100, 2019.
Artigo
em Inglês, Espanhol
| MEDLINE | ID: mdl-30711338
9.
Iron Deficiency Is a Determinant of Functional Capacity and Health-related Quality of Life 30 Days After an Acute Coronary Syndrome.
Rev Esp Cardiol (Engl Ed)
; 70(5): 363-370, 2017 May.
Artigo
em Inglês, Espanhol
| MEDLINE | ID: mdl-27838349
10.
Análisis del proceso de prescripción de inhibidores PCSK9 en los servicios de cardiología de los hospitales españoles y propuesta de optimización. Estudio IKIGAI / Analysis of the prescription process of PCSK9 inhibitors in the cardiology departments of Spanish hospitals and optimization proposal. The IKIGAI study
Clín. investig. arterioscler. (Ed. impr.)
; 33(6): 296-305, Nov-Dic. 2021. tab, graf
Artigo
em Espanhol
| IBECS (Espanha) | ID: ibc-221055
11.
In-hospital acquired anemia in acute coronary syndrome. Predictors, in-hospital prognosis and one-year mortality.
Rev Esp Cardiol (Engl Ed)
; 65(8): 742-8, 2012 Aug.
Artigo
em Inglês, Espanhol
| MEDLINE | ID: mdl-22709562
12.
Ceftolozane-tazobactam for the treatment of ventilator-associated infections by colistin-resistant Pseudomonas aeruginosa / Ceftolozano-tazobactam en el tratamiento de infecciones respiratorias asociadas a ventilación mecánica por Pseudomonas aeruginosa resistente a colistina
Rev. esp. quimioter
; 30(3): 224-228, jun. 2017. tab, graf
Artigo
em Inglês
| IBECS (Espanha) | ID: ibc-163235
13.
El déficit de hierro es un determinante de la capacidad funcional y de la calidad de vida a los 30 días tras un síndrome coronario agudo / Iron deficiency is a determinant of functional capacity and health-related quality of life 30 days after an acute coronary syndrome
Rev. esp. cardiol. (Ed. impr.)
; 70(5): 363-370, mayo 2017. graf, tab
Artigo
em Espanhol
| IBECS (Espanha) | ID: ibc-162914
14.
Iron Deficiency in Patients With Acute Coronary Syndrome: Prevalence and Predisposing Factors.
Rev Esp Cardiol (Engl Ed)
; 69(6): 615-7, 2016 Jun.
Artigo
em Inglês, Espanhol
| MEDLINE | ID: mdl-27105730
15.
Déficit de hierro en pacientes con síndrome coronario agudo: prevalencia y factores predisponentes / Iron deficiency in patients with acute coronary syndrome: Prevalence and predisposing factors
Rev. esp. cardiol. (Ed. impr.)
; 69(6): 615-617, jun. 2016. tab
Artigo
em Espanhol
| IBECS (Espanha) | ID: ibc-152980
16.
Una nueva estrategia para alcanzar los niveles objetivos de colesterol LDL tras un síndrome coronario agudo / A new rational approach to reach LDL-cholesterol concentration objectives after an acute coronary syndrome
Clín. investig. arterioscler. (Ed. impr.)
; 31(3): 93-100, mayo-jun. 2019. graf, tab
Artigo
em Espanhol
| IBECS (Espanha) | ID: ibc-182702
17.
Long-term outcome of transitory "reversible" complete atrio-ventricular block unrelated to myocardial ischemia.
Int J Cardiol
; 172(2): 503-5, 2014 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24491864
18.
Brugada phenocopy emerging as a new concept. Response.
Rev Esp Cardiol (Engl Ed)
; 66(9): 756, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24773691
19.
Hyperkalemia mimicking a pattern of Brugada syndrome.
Rev Esp Cardiol (Engl Ed)
; 66(4): 309, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24775622
20.
Myocardial infarction in South Asian immigrants in Catalonia. Results from the ASIAM Study.
Rev Esp Cardiol (Engl Ed)
; 66(5): 405-7, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24775827